Novel insights in the regulation and mechanism of androgen action on bone

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 20, Issue 3, 2013, Pages 240-244

  Sinnesael, Mieke ^a   Claessens, Frank ^b   Boonen, Steven ^b,c   Vanderschueren, Dirk ^a  

^a Division of Experimental Medicine and Endocrinology   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Androgens; Estrogens; FSH; Osteocalcin; Osteoporosis

Indexed keywords

ANDROGEN RECEPTOR; AROMATASE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; FOLLITROPIN; GROWTH HORMONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCALCIN; PROTEIN P66; REACTIVE OXYGEN METABOLITE; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C; TESTOSTERONE;

BINDING AFFINITY; BONE; BONE MASS; ESTROGEN DEFICIENCY; GENETIC POLYMORPHISM; HORMONAL REGULATION; HORMONE BINDING; HUMAN; LIQUID CHROMATOGRAPHY; NONHUMAN; OSTEOCYTE; PROTEIN EXPRESSION; REVIEW; SEX DIFFERENCE; TANDEM MASS SPECTROMETRY; TRABECULAR BONE; WEIGHT BEARING;

ANDROGENS; ANIMALS; BONE AND BONES; BONE DENSITY CONSERVATION AGENTS; BONE DEVELOPMENT; ESTROGENS; FEMALE; HUMANS; MALE; OSTEOBLASTS; OSTEOCALCIN; OSTEOCLASTS; OSTEOPOROSIS; RECEPTORS, ANDROGEN; RISK FACTORS; SEX CHARACTERISTICS; SIGNAL TRANSDUCTION; WEIGHT-BEARING;

EID: 84879210414     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0b013e32835f7d04     Document Type: Review

References (53)

1. Helsen C, Kerkhofs S, Clinckemalie L, et al. Structural basis for nuclear hormone receptor DNA binding. Mol Cell Endocrinol 2012; 348:411-417.
2. Vanderschueren D, Vandenput L, Boonen S, et al. Androgens and bone. Endocr Rev 2004; 25:389-425. (Pubitemid 38786452)
3. Callewaert F, Venken K, Ophoff J, et al. Differential regulation of bone and body composition in male mice with combined inactivation of androgen and estrogen receptor-alpha. FASEB J 2009; 23:232-240.
4. McNamara KM, Harwood DT, Simanainen U, et al. Measurement of sex steroids in murine blood and reproductive tissues by liquid chromatography- tandem mass spectrometry. J Steroid Biochem Mol Biol 2010; 121:611- 618.
5. Sjogren K, Lagerquist M, Moverare-Skrtic S, et al. Elevated aromatase expression in osteoblasts leads to increased bone mass without systemic adverse effects. J Bone Mineral Res 2009; 24:1263-1270.
6. Barrett-Connor E, Mueller JE, von Muhlen DG, et al. Low levels of estradiol are associated with vertebral fractures in older men, but not women: the Rancho Bernardo Study. J Clin Endocrinol Metab 2000; 85:219-223. (Pubitemid 32268817)
7. Goderie-Plomp HW, van der Klift M, de Ronde W, et al. Endogenous sex hormones, sex hormone-binding globulin, and the risk of incident vertebral fractures in elderly men and women: the Rotterdam Study. J Clin Endocrinol Metab 2004; 89:3261-3269. (Pubitemid 38951891)
8. Amin S, Zhang Y, Felson DT, et al. Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham Study. Am J Med 2006; 119:426-433.
9. Bjornerem A, Ahmed LA, Joakimsen RM, et al. A prospective study of sex steroids, sex hormone-binding globulin, and nonvertebral fractures in women and men: the Tromso Study. Eur J Endocrinol 2007; 157:119-125. (Pubitemid 47162575)
10. Mellstrom D, Vandenput L, Mallmin H, et al. Older men with low serum estradiol and high serum SHBG have an increased risk of fractures. J Bone Miner Res 2008; 23:1552-1560.
11. Meier C, Nguyen TV, Handelsman DJ, et al. Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study. Arch Intern Med 2008; 168:47-54.
12. Cauley JA, Ewing SK, Taylor BC, et al. Sex steroid hormones in older men: longitudinal associations with 4.5-year change in hip bone mineral density: the osteoporotic fractures in men study. J Clin Endocrinol Metab 2010; 95:4314-4323.
13. LeBlanc ES, Nielson CM, Marshall LM, et al. The effects of serum testosterone, estradiol, and sex hormone binding globulin levels on fracture risk in older men. J Clin Endocrinol Metab 2009; 94:3337-3346.
14. Barrett-Connor E, Laughlin GA, Li H, et al. The association of concurrent vitamin D and sex hormone deficiency with bone loss and fracture risk in older men: The osteoporotic fractures in men (MrOS) study. J Bone Miner Res 2012; 27:2306-2313.
15. Carani C, Qin K, Simoni M, et al. Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 1997; 337:91-95. (Pubitemid 27284394)
16. Maffei L, Murata Y, Rochira V, et al. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. J Clin Endocrinol Metab 2004; 89:61-70. (Pubitemid 38183860)
17. Morishima A, Grumbach MM, Simpson ER, et al. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995; 80:3689-3698.
18. Herrmann BL, Saller B, Janssen OE, et al. Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene. J Clin Endocrinol Metab 2002; 87:5476-5484. (Pubitemid 36034347)
19. Mittre Herve MH, Kottler ML, Pura M. Human gene mutations. Gene symbol: CYP19. Disease: aromatase deficiency. Hum Genet 2004; 114:224.
20. Bouillon R, Bex M, Vanderschueren D, et al. Estrogens are essential for male pubertal periosteal bone expansion. J Clin Endocrinol Metab 2004; 89:6025-6029. (Pubitemid 39628410)
21. Lanfranco F, Zirilli L, Baldi M, et al. A novel mutation in the human aromatase gene: insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment. Bone 2008; 43:628-635.
22. Riggs BL, Khosla S, Melton LJ. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Mineral Res 1998; 13:763-773. (Pubitemid 28224192)
23. Sun L, Peng Y, Sharrow AC, et al. FSH directly regulates bone mass. Cell 2006; 125:247-260.
24. Iqbal J, Li S, Kumar TR, et al. Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation. Proc Natl Acad Sci USA 2006; 103:14925-14930. (Pubitemid 44527830)
25. Allan CM, Kalak R, Dunstan CR, et al. Follicle-stimulating hormone increases bone mass in female mice. Proc Natl Acad Sci USA 2010; 107:22629- 22634.
26. Ly LP, Sartorius G, Hull L, et al. Accuracy of calculated free testosterone formulae in men. Clin Endocrinol (Oxf) 2010; 73:382-388.
27. Hackbarth JS, Hoyne JB, Grebe SK, et al. Accuracy of calculated free testosterone differs between equations and depends on gender and SHBG concentration. Steroids 2011; 76:48-55.
28. Egleston BL, Chandler DW, Dorgan JF. Validity of estimating nonsex hormone- binding globulin bound testosterone and oestradiol from total hormone measurements in boys and girls. Ann Clin Biochem 2010; 47:233-241.
29. Giton F, Fiet J, Guechot J, et al. Serum bioavailable testosterone: assayed or calculated? Clin Chem 2006; 52:474-481.
30. Ohlsson C, Wallaschofski H, Lunetta KL, et al. Genetic determinants of serum testosterone concentrations in men. PLoS Genet 2011; 7:e1002313.
31. Siiteri PK, Murai JT, Hammond GL, et al. The serum transport of steroid hormones. Recent progress in hormone research 1982; 38:457-510.
32. Lecomte P, Lecureuil N, Lecureuil M, et al. Age modulates effects of thyroid dysfunction on sex hormone binding globulin (SHBG) levels. Exp Clin Endocrinol Diabetes 1995; 103:339-342.
33. Lorentzon M, Swanson C, Andersson N, et al. Free testosterone is a positive, whereas free estradiol is a negative, predictor of cortical bone size in young Swedish men: the GOOD study. J Bone Miner Res 2005; 20:1334-1341. (Pubitemid 41033517)
34. Vanbillemont G, Lapauw B, Bogaert V, et al. Sex hormone-binding globulin as an independent determinant of cortical bone status in men at the age of peak bone mass. J Clin Endocrinol Metab 2010; 95:1579-1586.
35. Khosla S, Melton LJ 3rd, Atkinson EJ, et al. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab 1998; 83:2266-2274. (Pubitemid 28503012)
36. Almeida M, Han L, Martin-Millan M, et al. Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem 2007; 282:27285-27297. (Pubitemid 47501960)
37. Almeida M, Han L, Ambrogini E, et al. Oxidative stress stimulates apoptosis and activates NF-kappaB in osteoblastic cells via a PKCbeta/p66shc signaling cascade: counter regulation by estrogens or androgens. Mol Endocrinol 2010; 24:2030-2037.
38. Colvard DS, Eriksen EF, Keeting PE, et al. Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci USA 1989; 86:854-857. (Pubitemid 19056254)
39. Mizuno Y, Hosoi T, Inoue S, et al. Immunocytochemical identification of androgen receptor in mouse osteoclast-like multinucleated cells. Calcified Tissue Int 1994; 54:325-326. (Pubitemid 24097837)
40. Noble B, Routledge J, Stevens H, et al. Androgen receptors in bone-forming tissue. Horm Res 1999; 51:31-36. (Pubitemid 29154928)
41. Nakano Y, Morimoto I, Ishida O, et al. The receptor, metabolism and effects of androgen in osteoblastic MC3T3-E1 cells. Bone Miner 1994; 26:245- 259.
42. Gruber R, Czerwenka K, Wolf F, et al. Expression of the vitamin D receptor, of estrogen and thyroid hormone receptor alpha- and beta-isoforms, and of the androgen receptor in cultures of native mouse bone marrow and of stromal/ osteoblastic cells. Bone 1999; 24:465-473. (Pubitemid 29234135)
43. Masuyama A, Ouchi Y, Sato F, et al. Characteristics of steroid-hormone receptors in cultured Mc3t3-E1 osteoblastic cells and effect of steroidhormones on cell-proliferation. Calcified Tissue Int 1992; 51:376-381. (Pubitemid 23019418)
44. Notini AJ, McManus JF, Moore A, et al. Osteoblast deletion of exon 3 of the androgen receptor gene results in trabecular bone loss in adult male mice. J Bone Miner Res 2007; 22:347-356. (Pubitemid 46797117)
45. Chiang C, Chiu M, Moore AJ, et al. Mineralization and bone resorption are regulated by the androgen receptor in male mice. J Bone Miner Res 2009; 24:621-631.
46. Sinnesael M, Claessens F, Boonen S, et al. Targeted disruption of androgen receptor in mouse osteocytes: the androgen receptor in osteocytes is important for the maintenance of bone structure in males. Bone 2012; 50:S60-S.
47. Nakamura T, Imai Y, Matsumoto T, et al. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 2007; 130:811-823. (Pubitemid 47332572)
48. Oury F, Sumara G, Sumara O, et al. Endocrine regulation of male fertility by the skeleton. Cell 2011; 144:796-809.
49. Lee NK, Sowa H, Hinoi E, et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007; 130:456-469. (Pubitemid 47208519)
50. Kirmani S, Atkinson EJ, Melton LJ, et al. Relationship of testosterone and osteocalcin levels during growth. J Bone Mineral Res 2011; 26:2212-2216.
51. Callewaert F, Venken K, Kopchick JJ, et al. Sexual dimorphism in cortical bone size and strength but not density is determined by independent and timespecific actions of sex steroids and IGF-1: evidence from pubertal mouse models. J Bone Miner Res 2010; 25:617-626.
52. Lee K, Jessop H, Suswillo R, et al. Endocrinology: bone adaptation requires oestrogen receptor-alpha. Nature 2003; 424:389. (Pubitemid 36917478)
53. Callewaert F, Bakker A, Schrooten J, et al. Androgen receptor disruption increases the osteogenic response to mechanical loading in male mice. J Bone Miner Res 2010; 25:124-131.